Lung Cancer Study Group
N E W S
On May 18, to mark the European Oncology Nursing Day, the Lung Cancer Study Group (GECP) and the Portuguese Oncology Nursing Association (AEOP) launched a tribute campaign to all oncologist nurses. To celebrate this date, we invited three nurses to…
The Hotel Vila Galé, in Coimbra, will host a meeting organized jointly by the Lung Cancer Study Group (GECP) and the Respiratory Diseases Study Group (GRESP) of the Portuguese Association of General and Family Medicine (APMGF), with support of the…
After the recent opening of two Early Access Programs (PAP) to tepotinib and amivantamab (see news here!) for the treatment of two subtypes of lung cancer, INFARMED granted the request for a PAP to nivolumab in combination with ipilimumab for…
Did you know that today, Thursday, April 7, is World Health Day? This year, to mark this date, the Lung Cancer Study Group will publish a digital campaign with tips to take care of lung health… and beyond! Accept the…
Recently, INFARMED opened two new Early Access to Medicines Programs (PAP) for the treatment of lung cancer, which allow access to innovative therapies in two subtypes: the insertion of exon 20 of the EGFR and the skipping of exon 14…
Next March 31 at 6 pm Pulmonale will hold another webinar, on the theme “The Importance of Early Diagnosis of Lung Cancer” In a dialogue moderated by journalist Vera Arreigoso, Dr. Barbara Parente and Dr. Fernanda Estevinho will be chatting…
P U B L I C A T I O N S
New Therapeutic Approaches
2 1 Y E A R S O F H I S T O R Y I N P E R S P E C T I V E
S U P P O R T
